Jeffrey L Weinstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiography, Interventional | 6 | 2020 | 1095 | 0.940 |
Why?
|
Vena Cava Filters | 3 | 2023 | 252 | 0.920 |
Why?
|
Liver Transplantation | 5 | 2023 | 2119 | 0.890 |
Why?
|
Aneurysm, False | 1 | 2023 | 276 | 0.730 |
Why?
|
Electromagnetic Phenomena | 1 | 2020 | 161 | 0.710 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 3 | 2023 | 96 | 0.700 |
Why?
|
Hand | 2 | 2023 | 884 | 0.670 |
Why?
|
Radial Artery | 1 | 2020 | 194 | 0.670 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2022 | 277 | 0.670 |
Why?
|
Pulmonary Embolism | 5 | 2022 | 2376 | 0.640 |
Why?
|
Motor Skills | 1 | 2020 | 522 | 0.600 |
Why?
|
Catheterization, Peripheral | 1 | 2020 | 345 | 0.590 |
Why?
|
Benchmarking | 1 | 2023 | 1042 | 0.560 |
Why?
|
Ablation Techniques | 1 | 2018 | 249 | 0.510 |
Why?
|
Liver Neoplasms | 6 | 2023 | 4253 | 0.510 |
Why?
|
Thrombolytic Therapy | 5 | 2022 | 2161 | 0.480 |
Why?
|
Renal Dialysis | 1 | 2022 | 1786 | 0.430 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2214 | 0.430 |
Why?
|
Ultrasonography, Interventional | 3 | 2023 | 1486 | 0.410 |
Why?
|
Radiology, Interventional | 3 | 2022 | 460 | 0.410 |
Why?
|
Clinical Competence | 3 | 2023 | 4687 | 0.340 |
Why?
|
Embolization, Therapeutic | 4 | 2021 | 1392 | 0.330 |
Why?
|
Catheters | 2 | 2022 | 425 | 0.310 |
Why?
|
Graft Occlusion, Vascular | 2 | 2022 | 549 | 0.290 |
Why?
|
Fibrinolytic Agents | 3 | 2021 | 2158 | 0.270 |
Why?
|
Physicians | 1 | 2023 | 4567 | 0.260 |
Why?
|
Bile Duct Neoplasms | 2 | 2021 | 567 | 0.250 |
Why?
|
Internship and Residency | 1 | 2023 | 5788 | 0.220 |
Why?
|
Patient Readmission | 5 | 2020 | 3114 | 0.220 |
Why?
|
Vascular Patency | 2 | 2022 | 886 | 0.210 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 1475 | 0.210 |
Why?
|
Stents | 3 | 2023 | 3280 | 0.200 |
Why?
|
Surgery, Computer-Assisted | 1 | 2010 | 1018 | 0.200 |
Why?
|
Varicose Veins | 1 | 2023 | 154 | 0.200 |
Why?
|
Esophageal and Gastric Varices | 1 | 2023 | 207 | 0.190 |
Why?
|
Splenic Artery | 1 | 2021 | 54 | 0.190 |
Why?
|
Drug Costs | 1 | 2018 | 1105 | 0.190 |
Why?
|
Vena Cava, Inferior | 1 | 2023 | 440 | 0.190 |
Why?
|
Graft Survival | 2 | 2018 | 3737 | 0.170 |
Why?
|
Embolectomy | 1 | 2020 | 120 | 0.170 |
Why?
|
Pericardiectomy | 1 | 2019 | 45 | 0.170 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2019 | 86 | 0.170 |
Why?
|
Punctures | 1 | 2020 | 374 | 0.170 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 159 | 0.170 |
Why?
|
Peer Review, Health Care | 1 | 2019 | 75 | 0.160 |
Why?
|
Device Removal | 1 | 2023 | 656 | 0.160 |
Why?
|
Portal Vein | 2 | 2023 | 437 | 0.160 |
Why?
|
Empyema, Pleural | 1 | 2018 | 62 | 0.160 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2020 | 1354 | 0.150 |
Why?
|
Hepatic Artery | 1 | 2018 | 245 | 0.150 |
Why?
|
Patient Care Team | 2 | 2020 | 2531 | 0.150 |
Why?
|
Pericardial Effusion | 1 | 2019 | 247 | 0.150 |
Why?
|
Thrombectomy | 2 | 2023 | 680 | 0.140 |
Why?
|
Drainage | 2 | 2019 | 1142 | 0.140 |
Why?
|
Venous Thrombosis | 2 | 2023 | 1239 | 0.140 |
Why?
|
Foot Diseases | 1 | 2017 | 143 | 0.140 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 516 | 0.140 |
Why?
|
Hospital Mortality | 2 | 2020 | 5317 | 0.140 |
Why?
|
Fibroma | 1 | 2017 | 212 | 0.130 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2018 | 273 | 0.130 |
Why?
|
Treatment Outcome | 13 | 2023 | 63114 | 0.130 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4149 | 0.130 |
Why?
|
Graft Rejection | 1 | 2018 | 4397 | 0.130 |
Why?
|
Acute Disease | 2 | 2022 | 7149 | 0.130 |
Why?
|
Teaching Rounds | 1 | 2019 | 253 | 0.130 |
Why?
|
End Stage Liver Disease | 1 | 2018 | 314 | 0.120 |
Why?
|
Angioplasty, Balloon | 1 | 2018 | 653 | 0.120 |
Why?
|
Time Factors | 4 | 2023 | 40075 | 0.120 |
Why?
|
Humans | 31 | 2023 | 744343 | 0.120 |
Why?
|
Angioplasty | 1 | 2016 | 364 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 639 | 0.110 |
Why?
|
Cryosurgery | 1 | 2017 | 453 | 0.110 |
Why?
|
Hepatectomy | 1 | 2016 | 550 | 0.110 |
Why?
|
Ultrasonography | 2 | 2023 | 5985 | 0.110 |
Why?
|
Postoperative Complications | 3 | 2021 | 15295 | 0.100 |
Why?
|
Hemorrhage | 2 | 2020 | 3461 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2020 | 5078 | 0.090 |
Why?
|
Yttrium Radioisotopes | 2 | 2021 | 93 | 0.090 |
Why?
|
Intubation, Intratracheal | 1 | 2018 | 1364 | 0.090 |
Why?
|
Retrospective Studies | 10 | 2023 | 77449 | 0.090 |
Why?
|
Learning | 1 | 2019 | 1713 | 0.090 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3670 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1540 | 0.080 |
Why?
|
Microspheres | 2 | 2021 | 777 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1831 | 0.080 |
Why?
|
Pilot Projects | 1 | 2020 | 8324 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2020 | 3528 | 0.070 |
Why?
|
Italy | 1 | 2018 | 832 | 0.070 |
Why?
|
Quality Improvement | 2 | 2018 | 3749 | 0.070 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4933 | 0.070 |
Why?
|
Middle Aged | 15 | 2023 | 213383 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8642 | 0.070 |
Why?
|
Mortality | 1 | 2017 | 2864 | 0.070 |
Why?
|
Telemedicine | 1 | 2022 | 2872 | 0.060 |
Why?
|
Consensus | 3 | 2019 | 2959 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3143 | 0.060 |
Why?
|
Liver | 2 | 2018 | 7474 | 0.060 |
Why?
|
Male | 17 | 2023 | 350118 | 0.060 |
Why?
|
Intracranial Hemorrhages | 2 | 2020 | 855 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2023 | 1130 | 0.060 |
Why?
|
Pediatrics | 1 | 2018 | 3475 | 0.060 |
Why?
|
Transplantation Tolerance | 1 | 2018 | 617 | 0.060 |
Why?
|
Cost Savings | 1 | 2018 | 926 | 0.060 |
Why?
|
Systems Analysis | 1 | 2023 | 172 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4262 | 0.050 |
Why?
|
Anticoagulants | 1 | 2017 | 4599 | 0.050 |
Why?
|
Ascites | 1 | 2023 | 344 | 0.050 |
Why?
|
Patient Satisfaction | 2 | 2023 | 3396 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7181 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 295 | 0.050 |
Why?
|
Cholangiography | 1 | 2019 | 189 | 0.040 |
Why?
|
Forms and Records Control | 1 | 2019 | 160 | 0.040 |
Why?
|
Echocardiography | 2 | 2022 | 5102 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 10900 | 0.040 |
Why?
|
Chest Tubes | 1 | 2018 | 150 | 0.040 |
Why?
|
Risk Factors | 5 | 2020 | 72290 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 2018 | 341 | 0.040 |
Why?
|
Female | 12 | 2022 | 380194 | 0.040 |
Why?
|
Aged | 8 | 2023 | 163280 | 0.040 |
Why?
|
Length of Stay | 2 | 2020 | 6309 | 0.040 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2017 | 129 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 642 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 53288 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2023 | 2453 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5391 | 0.030 |
Why?
|
Delphi Technique | 1 | 2018 | 778 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2020 | 565 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1107 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1486 | 0.030 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 581 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3251 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1850 | 0.030 |
Why?
|
Hypertrophy | 1 | 2016 | 569 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1907 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 847 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13695 | 0.030 |
Why?
|
Foot | 1 | 2017 | 527 | 0.030 |
Why?
|
Databases, Factual | 1 | 2018 | 7729 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1928 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1573 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1863 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2022 | 2708 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18370 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1035 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2728 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3218 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3584 | 0.020 |
Why?
|
Heart Arrest | 1 | 2019 | 1470 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5007 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4201 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2569 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2020 | 3821 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3420 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5097 | 0.020 |
Why?
|
Adult | 4 | 2019 | 214055 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4851 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3589 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39050 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9313 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6566 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13408 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4215 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8663 | 0.020 |
Why?
|
Survival Rate | 1 | 2017 | 12788 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29063 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40561 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35136 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 41006 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23338 | 0.010 |
Why?
|
United States | 1 | 2023 | 69872 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56430 | 0.010 |
Why?
|